A New Treatment for Alzheimer’s Disease and the Controversy Surrounding It | SB Estate Planning & Elder Law
The Food and Drug Administration (FDA) has approved a drug purported to slow the progress of Alzheimer’s disease. However, the decision is not without controversy. A recent article by AARP explores this subject in some detail. Here is a synopsis.